Baird’s Acadia Healthcare ACHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
$41.4M Sell
578,295
-222,284
-28% -$14.3M 0.42% 64
2014
Q4
$49M Buy
800,579
+25,122
+3% +$1.46M 0.52% 41
2014
Q3
$37.6M Buy
775,457
+25,179
+3% +$1.23M 0.53% 53
2014
Q2
$34.1M Buy
750,278
+62,994
+9% +$2.77M 0.48% 62
2014
Q1
$31M Buy
687,284
+360,831
+111% +$17.8M 0.45% 64
2013
Q4
$15.5M Buy
326,453
+38,930
+14% +$1.69M 0.27% 108
2013
Q3
$11.3M Buy
287,523
+92,863
+48% +$3.45M 0.21% 134
2013
Q2
$6.44M Buy
+194,660
New +$6.32M 0.13% 206

Other funds holding ACHC

Baird's ACHC Position: Q1 2015 in Review

Baird reduced its Acadia Healthcare (ACHC) stake by 28% in Q1 2015, selling an estimated $14.3M and leaving 578,295 shares worth $41.4M. The position accounts for 0.42% of the portfolio, ranked #64.

Baird first reported a position in ACHC in Q2 2013 and has held it in 8 quarters since. The position peaked at $49M in Q4 2014. 209 funds tracked by Wall St. Rank hold ACHC as of Q1 2015.

  • Baird held 578,295 shares of Acadia Healthcare worth $41.4M as of Q1 2015.
  • Baird sold 222,284 Acadia Healthcare shares in Q1 2015, an estimated $14.3M.
  • Acadia Healthcare made up 0.42% of Baird's portfolio in Q1 2015, its #64 holding.
  • Baird first reported a position in Acadia Healthcare in Q2 2013 and has held it in 8 quarters since.
  • Baird's Acadia Healthcare position peaked at $49M in Q4 2014.
  • 209 funds tracked by Wall St. Rank held Acadia Healthcare as of Q1 2015.

Based on Baird's 13F filing for Q1 2015, filed 13 May 2015.